(Q36212679)

12 August 2017

Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis (English)

1 reference

logistic regression model

12 August 2017

1 reference

1 reference

inferred from title

multivariate statistics

1 reference

1 reference

Zehra B Omer

1

1 reference

12 August 2017

Ashwin N Ananthakrishnan

2

1 reference

12 August 2017

Kevin J Nattinger

3

1 reference

12 August 2017

Elisabeth B Cole

4

1 reference

12 August 2017

Jesse J Lin

5

1 reference

12 August 2017

Chung Yin Kong

6

1 reference

12 August 2017

Chin Hur

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

15 March 2012

1 reference

Clinical Gastroenterology and Hepatology

12 August 2017

1 reference

12 August 2017

10

1 reference

12 August 2017

7

1 reference

12 August 2017

722-727

1 reference

Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Secular trends in patients diagnosed with Barrett's esophagus

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

COX-2 Inhibition in Esophagitis, Barretts Esophagus and Esophageal Cancer

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Gastric acid secretion and parietal cell mass: effect of sex hormones.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

The use of nonsteroidal anti-inflammatory drugs and the risk of Barrett's oesophagus.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Effect of acid suppression on molecular predictors for esophageal cancer

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Binge drinking among US adults

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435144

5 December 2018

1 reference

12 December 2020

Long term continuous omeprazole treatment of patients with Barrett's oesophagus

1 reference

12 December 2020

Cyclooxygenase-2 expression in human esophageal carcinoma

1 reference

12 December 2020

Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression

1 reference

12 December 2020

Cyclooxygenase-2 expression in Barrett's esophagus

1 reference

12 December 2020

10.1016/J.CGH.2012.02.031

Identifiers

DOI

1 reference

release_nblprngzondm3aom4tukq2gkwy

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nblprngzondm3aom4tukq2gkwy

24 November 2022

mapped directly with Wikidata item

1 reference

12 August 2017

PubMed publication ID

22426086

1 reference